Susan Stewart Selected Research

Transforming Growth Factor beta (TGF-beta)

4/2002

Primary pulmonary hypertension is associated with reduced pulmonary vascular expression of type II bone morphogenetic protein receptor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Susan Stewart Research Topics

Disease

6	Neoplasms (Cancer) 07/2021 - 12/2002
3	Cataract (Cataracts) 01/2020 - 06/2005
3	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2012 - 02/2011
3	Bronchiolitis 01/2005 - 02/2002
2	Breast Neoplasms (Breast Cancer) 03/2016 - 03/2004
2	Tobacco Use Disorder (Nicotine Dependence) 10/2015 - 11/2007
2	Pulmonary Hypertension 07/2011 - 04/2002
1	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2022
1	Neoplasm Metastasis (Metastasis) 07/2021
1	Colonic Neoplasms (Colon Cancer) 07/2021
1	Skin Neoplasms (Skin Cancer) 01/2020
1	Herpes Zoster 01/2020
1	Multiple Myeloma 01/2020
1	Osteoporosis 01/2020
1	Lymphoma (Lymphomas) 01/2020
1	Metabolic Bone Diseases (Osteopenia) 01/2020
1	Osteogenesis Imperfecta (Lobstein Disease) 01/2017
1	ST Elevation Myocardial Infarction 07/2016
1	Thrombosis (Thrombus) 07/2016
1	Colorectal Neoplasms (Colorectal Cancer) 12/2014
1	Vasculitis (Vasculitides) 07/2011
1	Schistosomiasis (Bilharziasis) 02/2010
1	Vascular Remodeling 02/2010
1	Glioma (Gliomas) 11/2009
1	Congenital Heart Defects (Congenital Heart Defect) 10/2009
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 02/2008
1	Adenocarcinoma 11/2007
1	Idiopathic Pulmonary Fibrosis 11/2007
1	Infections 08/2007
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2006
1	Tracheobronchomegaly (Mounier Kuhn Syndrome) 01/2006
1	Microsatellite Instability 02/2005
1	Liver Cirrhosis (Hepatic Cirrhosis) 02/2005
1	Emphysema 02/2005
1	Bronchiolitis Obliterans Syndrome 01/2005
1	Familial Primary Pulmonary Hypertension 04/2002

Drug/Important Bio-Agent (IBA)

1	CalciumIBA 01/2017
1	omega-Chloroacetophenone (Mace)IBA 07/2016
1	MetalsIBA 07/2016
1	Biomarkers (Surrogate Marker)IBA 03/2016
1	Nicotine FDA Link 10/2015
1	CytokinesIBA 02/2010
1	Chemokine ReceptorsIBA 10/2009
1	SmokeIBA 11/2007
1	DNA (Deoxyribonucleic Acid)IBA 02/2005
1	PolymersIBA 02/2005
1	Peptide Hydrolases (Proteases)FDA Link 02/2005
1	Estrogen ReceptorsIBA 12/2002
1	Hormones (Hormone)IBA 12/2002
1	Transforming Growth Factor beta (TGF-beta)IBA 04/2002
1	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 04/2002

Therapy/Procedure

6	Therapeutics 01/2020 - 12/2002
4	Lung Transplantation 11/2007 - 02/2002
2	Cell Transplantation 01/2022 - 01/2020
2	Drug Therapy (Chemotherapy) 07/2021 - 03/2016
2	Adjuvant Chemotherapy 01/2019 - 03/2016
2	Aftercare (After-Treatment) 03/2016 - 03/2004
2	Segmental Mastectomy (Lumpectomy) 02/2011 - 12/2002
2	Radiotherapy 02/2011 - 12/2002
2	Transplantation 08/2007 - 01/2005
2	Local Anesthesia 06/2005 - 06/2005
1	Hepatectomy 07/2021
1	Infusion Pumps (Infusion Pump) 07/2021
1	Replacement Arthroplasty 01/2020
1	Stents 07/2016
1	Drug-Eluting Stents 07/2016
1	Percutaneous Coronary Intervention 07/2016
1	Traditional Medicine (Folk Remedies) 12/2014
1	Mammaplasty (Breast Reconstruction) 10/2011
1	Mastectomy (Mammectomy) 10/2011
1	Endarterectomy (Thromboendarterectomy) 07/2011
1	Complementary Therapies (Alternative Medicine) 11/2009
1	Hematopoietic Stem Cell Transplantation 02/2008
1	Pneumonectomy (Lung Volume Reduction) 11/2007
1	Anesthesia 06/2005
1	Heart-Lung Transplantation 04/2002